Clinical trials
Obesity clinical trials
Excess body weight that increases the risk of many other health conditions. We’re tracking 1,434 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04014413Recruiting
Fecal transplant for gut and immune-related conditions
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
Hong Kong, ShatinAges Any age - NCT07750223Recruiting
Hesperidin for memory and thinking in older adults
This study tests whether a natural supplement called hesperidin (found in citrus fruits) can support brain health in older adults who are overweight or obese. It may help with memory and thinking.
Shanghai, Shanghai MunicipalityAges 55–75 - NCT06595134Recruiting
AI heart scan study for people with obesity
This study is testing an AI tool to improve heart scans in people with obesity who may have hidden heart disease. If you are 45 or older, have a BMI of 30 or higher, and your doctor thinks you might have heart problems, this study could help find them earlier.
ViennaAges 45 years+ - NCT07745504RecruitingPhase 3
Comparing two versions of a new weight-loss medication
This study compares two different versions of an investigational weight-loss medication (cagrilintide) against a placebo to see which is more effective and safe for people with excess weight. Participation involves receiving injections and regular check-ins to monitor your progress.
Conyers, GeorgiaAges 18 years+ - NCT07747857RecruitingPhase 1
Study of TQF3250 capsules for type 2 diabetes with overweight or obesity
This study tests a new capsule medicine for adults with type 2 diabetes who are overweight or have obesity. The goal is to see if it helps control blood sugar and weight.
Fuzhou, FujianAges 18–70 - NCT07743983RecruitingPhase 3
Study of BGM0504 in Early Type 2 Diabetes with Obesity
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
Nanjing, JiangsuAges 18–75 - NCT07742917Recruiting
Personalized lifestyle program for weight management
This program tests a personalized lifestyle plan designed to help you manage your weight and improve your health. It uses your genetic information and other personal data to tailor the support you receive.
Abu DhabiAges 25–50 - NCT07743567Recruiting
Weight and pregnancy outcomes after GLP-1 use
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
Kansas City, KansasAges 18–45 - NCT07748949Recruiting
Low-calorie diet and lifestyle help for type 2 diabetes
This study tests whether a low-calorie diet combined with a personalized lifestyle program can help people with type 2 diabetes reach remission, meaning their blood sugar stays normal without needing diabetes medication. It uses a smartphone app to support the program.
BangkokAges 18–70 - NCT07746635Recruiting
Fecal transplant for obese women with polyendocrine ovarian syndrome
This study tests whether a fecal microbiota transplant (putting healthy bacteria from a donor into your gut) can help women with polyendocrine ovarian syndrome and obesity improve their chances of a successful frozen embryo transfer. It may help by balancing the bacteria in your gut, which could improve your overall health and fertility.
Shanghai, Shanghai MunicipalityAges 20–40 - NCT07747779Recruiting
Comparing two weight-loss surgeries for very high body weight
This study compares two types of weight-loss surgery to see how they affect hormones after a meal. It may help you choose a surgery that improves your health and weight loss.
Pathum Wan, BangkokAges 18–60 - NCT07738029Recruiting
Intensive lifestyle treatment for children with obesity and their families
This trial studies a 1-year intensive lifestyle program for children ages 10-16 with a high body mass index (ISO-BMI ≥30) and their families. It aims to help children who have struggled to lose weight with lifestyle changes alone.
Tampere, PirkanmaaAges 10–16 - NCT07740291Recruiting
Tirzepatide and lifestyle study for weight loss
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
Lubbock, TexasAges 18 years+ - NCT07732738Recruiting
Bariatric surgery plus GLP-1 drug for weight loss and diabetes
This study tests if adding a GLP-1 medication to weight-loss surgery helps people with obesity and related conditions like diabetes. It may improve weight loss and blood sugar control more than surgery alone.
Xingtai, HebeiAges 16–70 - NCT07724522Recruiting
Prebiotic Fiber for Irregular Periods in Women
This study tests whether taking a prebiotic fiber (inulin) can help women who are in the later years of their reproductive life (before menopause) and have irregular periods. You may be eligible if you are overweight, have irregular cycles, sit a lot, and do not exercise much.
Washington D.C., District of ColumbiaAges 40–55 - NCT07728669Recruiting
Digital diet app for people on GLP-1 therapy
This study tests a smartphone app that gives dietary advice to people who are overweight or obese and also take a GLP-1 medication (like semaglutide) for weight or diabetes. The app will help you follow a healthy eating plan while using the medication.
AlmatyAges 21–65 - NCT05602805Recruiting
Study using a health data bank for weight management
This study builds a data bank to help track how people manage overweight or obesity at the hospital. It may help improve care for future patients by learning what treatments and outcomes work best.
Québec, QuebecAges 18 years+ - NCT07720271RecruitingPhase 3
Zenagamtide weight loss study for adults
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
Anniston, AlabamaAges 18 years+ - NCT07718126RecruitingPhase 4
Pre-surgery rehab for obese liver donors with MASLD using Mazdutide
This trial tests if a medicine called Mazdutide can help overweight living liver donors who have a fatty liver condition (MASLD) lose weight and improve their liver health before donating part of their liver. It aims to make the donation safer and more successful.
Hefei, AnhuiAges 18–60 - NCT07715955Recruiting
Can probiotics help control appetite in adults with overweight or obesity?
This study tests whether taking probiotics can help regulate appetite in people who are overweight or have obesity. It aims to understand if these supplements can support weight management by affecting hunger and fullness signals.
Maastricht, LimburgAges 20–70 - NCT07717658Recruiting
Family weight wellness program for teens and parents
This study tests a weight wellness program that uses food support and group medical visits for teens and their parents. It aims to help families adopt healthier habits together over 12 months.
Boston, MassachusettsAges 12–17 - NCT07717333Recruiting
Sarcopenia signs after weight loss surgery
This study looks at muscle changes after bariatric (weight loss) surgery. It may help you understand how your muscles are affected and what you can do to stay strong.
Istanbul, KÜÇÜKÇEKMECEAges 18–65 - NCT07710729RecruitingPhase 1
How UBT251 Affects Birth Control and Stomach Emptying
This study tests a new medicine, UBT251, to see if it affects how birth control pills work and how quickly food leaves the stomach. It is for women with overweight or obesity who cannot get pregnant.
Montreal, QuebecAges 18–65 - NCT07710768RecruitingPhase 1
A study on how UBT251 affects certain drugs in people with extra weight
This study tests if a new medicine called UBT251 changes how the body processes caffeine, midazolam (a sedative), and warfarin (a blood thinner). It is for generally healthy adults with a Body Mass Index (BMI) between 27 and 40.
Cypress, CaliforniaAges 18–65
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity?
- Yes. Clin2 currently lists 1,434 recruiting obesity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.